At CareMetx, we are proud of our longstanding history in the patient advocacy space. From the very beginning, our focus has been deeply rooted in one common theme- that patients are the priority.
The roots of CareMetx trace back to the 1984 founding of the Cystic Fibrosis foundation, an organization that at the time sponsored research, championed therapy manufacturers, and advocated for patients. Over the years, the foundation grew into what became the nation’s first disease-specific specialty pharmacy, led by Bob Dresing- the leader who went on to co-found CareMetx alongside today’s CEO, Mark Hansan. Our CareMetx values have always been championed by a team of leaders like Bob and Mark- dedicated individuals who have successfully advocated for patients and manufacturers for over 30 years.
This history is one that continues to inspire the work we do. Our clients trust us because we fully grasp the enormous responsibility we assume on their behalf when delivering our services to meet all stakeholder needs. That’s why CareMetx now supports a multibillion dollar portfolio of products. We have helped manufacturers launch their very first product to market. We’ve helped clients transition single products or multiple franchises from underperforming vendors. We’ve helped customers deploy FDA-mandated Risk Evaluation and Mitigation Strategy programs. And above all, we’ve helped 2,673,387 patients get access to their medication faster. This longstanding history of patient support and stakeholder success speaks to why today’s clients trust us to continually innovate to find faster, smarter, better ways to serve their patients- and by doing so, to serve them.